• 2009

Company Description

Ablexis is a biotechnology company developing an innovative, next-generation platform for antibody drug discovery.

Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.